Anastasia A. Fadeeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anastasia A. Fadeeva has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Aleksei D. Barykin
Department of Biomolecular Chemistry Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences Moscow Russia
1 shared publication - Alexander S. Mishin
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
1 shared publication - Anastasia A. Andrianova
Department of Biomolecular Chemistry Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences Moscow Russia
1 shared publication - Anastasiia S. Garanina
Laboratory of Biomedical Nanomaterials, National University of Science and Technology MISIS, 4 Leninskiy pr, Moscow 119049, Russia
1 shared publication - Andrey A. Tabolin
N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky prosp. 47, Moscow, 119991, Russian Federation
1 shared publication - Andrey Bubyrev
Department of Biomolecular Chemistry Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences Moscow Russia
1 shared publication
Latest Publications
- 13 October 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (19) , e70554
Chemical Tuning of Fungal Bioluminescence in Mammalian Systems
Fungal bioluminescence is a genetically encodable platform with potential for bioimaging in mammalian systems but remains limited by low signal intensity. Here, we report a series of fungal luciferin analogs designed by modification of the arylidene fragment. Electron‐donating substituents generally increase activity, whereas extension of π ‐conjugation red‐shifts emission, with partial decoupling of these effects. These trends parallel those observed for firefly luciferins, indicating that empirical design principles can be transferred between the two systems. Evaluation across fungal luciferases and engineered variant v4, demonstrated broad substrate compatibility and highlighted the combined potential of luciferase engineering and luciferin modification for improving fungal bioluminescence in mammalian bioimaging.
- 13 October 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (19) , e70554
Chemical Tuning of Fungal Bioluminescence in Mammalian Systems
Fungal bioluminescence is a genetically encodable platform with potential for bioimaging in mammalian systems but remains limited by low signal intensity. Here, we report a series of fungal luciferin analogs designed by modification of the arylidene fragment. Electron‐donating substituents generally increase activity, whereas extension of π ‐conjugation red‐shifts emission, with partial decoupling of these effects. These trends parallel those observed for firefly luciferins, indicating that empirical design principles can be transferred between the two systems. Evaluation across fungal luciferases and engineered variant v4, demonstrated broad substrate compatibility and highlighted the combined potential of luciferase engineering and luciferin modification for improving fungal bioluminescence in mammalian bioimaging.
- Open Access
- 27 March 2025
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 2025(2)
Modern tumor imaging models for rodents: potential and prospects in translational medicine
Rodent neoplastic process models are extensively used in pre-clinical practice to assess the dynamics of tumor development and test anti-cancer drugs, which ensures flexibility of choosing both basic and advanced personalized tumor development models for researchers. Various modern model tumor imaging methods are considered, including fluorescence and bioluminescence imaging, which enable comprehensive assessment, from qualitative evaluation to in vivo monitoring. We believe that the development of autonomous bioluminescent systems in mammalian cells will provide new possibilities for noninvasive imaging of animal physiological processes, including long-term monitoring of tumor progression.
- 27 March 2025
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 2025(2)
Open AccessModern tumor imaging models for rodents: potential and prospects in translational medicine
Rodent neoplastic process models are extensively used in pre-clinical practice to assess the dynamics of tumor development and test anti-cancer drugs, which ensures flexibility of choosing both basic and advanced personalized tumor development models for researchers. Various modern model tumor imaging methods are considered, including fluorescence and bioluminescence imaging, which enable comprehensive assessment, from qualitative evaluation to in vivo monitoring. We believe that the development of autonomous bioluminescent systems in mammalian cells will provide new possibilities for noninvasive imaging of animal physiological processes, including long-term monitoring of tumor progression.
- 1 June 2021
- Published by Elsevier in Tetrahedron Letters
- Vol. 73
Dehydration of isoxazoline N-oxides under electrophilic conditions – An alternative approach toward 3-haloisoxazoles
- 1 June 2021
- Published by Elsevier in Tetrahedron Letters
- Vol. 73
Dehydration of isoxazoline N-oxides under electrophilic conditions – An alternative approach toward 3-haloisoxazoles